New cancer clinical trial: Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Published on: November 29, 2018 at 12:00PM
Conditions:   Cancer;   Abdominal Cancer;   Pelvic Cancer;   Metastatic Cancer;   Peritoneal Metastases;   Liver Metastases
Interventions:   Device: Thermotron RF-8EX;   Biological: Adoptive cellular Immunotherapy;   Drug: Anti-PD-1 antibody;   Drug: Chemotherapy
Sponsor:   Capital Medical University
Recruiting
https://ift.tt/2PaHEtL